CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC). HISTORICAL PERSPECTIVE
Abstract
Purpose: to analyze scientific publications on cytoreductive surgery with intra-abdominal hyperthermic chemotherapy (HIPEC)procedure.Material and methods: foreign and domestic scientific publications.Results and discussion. In the foreign literature, the results of clinical studies evaluating the effectiveness of CRS/HIPEC compared to CRS in patients with peritoneal carcinomatosis of various etiologies have been published, while long-term survival rates were higher in the group who underwent CRS/HIPEC. Despite the fact that there is a sufficient variety of multicenter retrospectivestudies on the treatment of peritoneal carcinomatosis of various etiologies, there is still no clear answer defining indications and contraindications for performing CRS/HIPEC.Conclusions. The treatment of peritoneal carcinomatosis and the evolution of the HIPEC procedure is aimed at optimizing different treatment methods at many levels, including patient selection, preoperative preparation, and determining the safest and most effective chemotherapy regimens. More research is needed in the field of CRS/HIPEC, which will undoubtedly help to further standardize this technique.
About the Authors
M. V. Zabelin
ФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА России
Russian Federation
Russian Federation
A. S. Safonov
ФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА России; ГБУЗ «Республиканская клиническая больница им. Г.Г. Куватова»
Russian Federation
Russian Federation
N. V. Kuznetsov
ГБУЗ «Республиканская клиническая больница им. Г.Г. Куватова»
Russian Federation
Russian Federation
References
1. Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments / F. Roviello [et al.] // Surg. Oncol. - 2011. - Vol. 20, № 1. - P. e38-54
2. Meigs, J.V. Tumors of the female pelvic organs /j.V. Meigs. - New York: The Macmillan Company, 1934. - 533 p
3. Ovarian carcinoma: improved survival following abdominopelvic irradiation in patients with a completed pelvic operation / A.J. Dembo [et al.] // Am. J. Obstet. Gynecol. - 1979. - Vol. 134, № 7. - P. 793-800
4. Improved chemotherapy for ovarian cancer with cisdiamminedichloroplatinum and adriamycin. / H.W. Bruckner [et al.] // Cancer. - 1981. - Vol. 47, № 9. - P. 2288-2294
5. Munnell, E.W. The changing prognosis and treatment in cancer of the ovary. A report of 235 patients with primary ovarian carcinoma 1952-1961 / E.W. Munnell // Am. J. Obstet. Gynecol. - 1968. - Vol. 100, № 6. - P. 790-805
6. Munnell, E.W. Surgical treatment of ovarian carcinoma / E.W. Munnell // Clin. Obstet. Gynecol. - 1969. - Vol. 12, № 4. - P. 980-992
7. Griffiths, C.T. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma / C.T. Griffiths // Natl. Cancer Inst. Monogr. - 1975. - Vol. 42. - P. 101-104
8. Griffiths, C.T. Role of cytoreductive surgical treatment in the management of advanced ovarian cancer / C.T. Griffiths, L.M. Parker, A.F. Fuller Jr. // Cancer Treat. Rep. - 1979. - Vol. 63, № 2. - P. 235-240
9. Long R.T. Pseudomyxoma peritonei. New concepts in management with a report of seventeen patients / R.T. Long, J.S. Spratt Jr, E. Dowling. Am. J. Surg. - Vol. 117, № 2. - P. 162-169
10. Ghosh, B.C. Pseudomyxoma peritonei / B.C. Ghosh, A.G. Huvos, H.W. Whiteley // Dis. Colon Rectum. - 1972. - Vol. 15, № 6. - P. 420-425
11. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer / R.L. Dedrick [et al.] // Cancer Treat. Rep. - 1978. - Vol. 62, № 1. - P. 1-11
12. Comparison of the iv and ip routes of administration of cisplatin in dogs / R.G. Pretorius [et al.] // Cancer Treat. Rep. - 1981. - Vol. 65, № 11-12. - P. 1055-1062
13. Palta, J.R. Design and testing of a therapeutic infusion filtration system /j.R. Palta // M.S. thesis. - Columbia: University of Missouri, 1977
14. Systemic thermotherapy: description of a method and physiologic tolerance in clinical subjects /j.M. Larkin [et al.] // Cancer. - 1977. - Vol. 40, № 6. - P. 3155-3159
15. Hyperthermic peritoneal perfusion system in canines /j.S. Spratt [et al.] // Cancer Res. - 1980. - Vol. 40, № 2. - P. 253-255
16. Clinical delivery system for intraperitoneal hyperthermic chemotherapy /j.S. Spratt [et al.] // Cancer Res. - 1980. - Vol. 40, № 2. - P. 256-260
17. Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide / S. Zimm [et al.] // Cancer Res. - 1987. - Vol. 47, № 6. - P. 1712-1716
18. Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy / S.B. Howell [et al.] //j. Clin. Oncol. - 1987. - Vol. 5, № 10. - P. 1607-1612
19. Sugarbaker, P.H. Surgical management of peritoneal carcinosis: diagnosis, prevention and treatment / P.H. Sugarbaker // Langenbecks Arch. Chir. - 1988. - Vol. 373, № 3. - P. 189-196
20. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors / D.Z. Chu [et al.] // Cancer. - 1989. - Vol. 63, № 2. - P. 364-367
21. Sugarbaker, P.H. Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction intraperitoneal chemotherapy / P.H. Sugarbaker // Cancer Treat. Res. - 1996. - Vol. 82. - P. 317-325
22. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug / S. Koga [et al.] // Cancer Res. - 1984. - Vol. 44, № 5. - P. 1840-1842
23. Koga, S. Prophylactic and therapeutic continuous hyperthermic peritoneal perfusion for peritoneal metastases of gastric cancer / S. Koga // Gan No Rinsho. - 1985. - Vol. 31, 9 Suppl. - P. 1103-1105
24. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding / S. Fujimoto [et al.] // Ann. Surg. - 1988. - Vol. 208, № 1. - P. 36-41
25. Sugarbaker, P.H. Peritonectomy procedures / P.H. Sugarbaker // Ann. Surg. - 1995. - Vol. 221, № 1. - P. 29-42
26. Peritonectomy and intraperitoneal chemotherapy in appendiceal and colorectal cancer / K.W. Horsell [et al.] // Aust. N. Z. J. Surg. - 1999. - Vol. 69, № 10. - P. 729-732
27. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study / F.N. Gilly [et al.] // Anticancer Res. - 1999. - Vol. 19, № 3В. - P. 2317-2321
28. Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion / O. Glehen [et al.] //j. Surg. Oncol. - 2008. - Vol. 98, № 4. - P. 242-246
29. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique / A.D. Stephens [et al.] // Ann. Surg. Oncol. - 1999. - Vol. 6, № 8. - P. 790-796
30. Effects of intraabdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration / P. Jacquet [et al.] // Anticancer Drugs. - 1996. - Vol. 7, № 5. - P. 596-603
31. Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection / D. Elias [et al.] // Int. J. Surg. Investig. - 2000. - Vol. 1, № 5. - P. 431-439
32. Intraperitoneal chemohyperthermia with "overflow" open abdomen / P. Rat [et al.] // Ann. Chir. - 2001. - Vol. 126, № 7. - P. 669-671
33. Jacquet, P. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis / P. Jacquet, P.H. Sugarbaker // Cancer Treat. Res. - 1996. - Vol. 82. - P. 359-374
34. Esquivel, J. Elective surgery in recurrent colon cancer with peritoneal seeding: when to and when not to proceed /j. Esquivel, A. Farinetti, P.H. Sugarbaker // G. Chir. - 1999. - Vol. 20, № 3. - P. 81-86
35. Harmon, R.L. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer / R.L. Harmon, P.H. Sugarbaker // Int. Semin. Surg. Oncol. - 2005. - Vol. 2, № 1. - P. 3
36. Sugarbaker, P.H.Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis / P.H. Sugarbaker // Semin. Surg. Oncol. - 1998. - Vol. 14, № 3. - P. 254-261
37. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy / D. Elias [et al.] // Cancer. - 2001. - Vol. 92, № 1. - P. 71-76
38. Locoregional treatment of peritoneal carcinomatosis from gastric cancer / F. Bozzetti [et al.] //j. Surg. Oncol. - 2008. - Vol. 98, № 4. - P. 273-276
39. Glockzin, G. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy / G. Glockzin, H.J. Schlitt, P. Piso // World J. Surg. Oncol. - 2009. - Vol. 7. - P. 5
40. Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis / F.N. Gilly [et al.] // Hepatogastroenterology. - 1994. - Vol. 41, № 2. - P. 124-129
41. Kajitani, T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification / T. Kajitani // Jpn. J. Surg. - 1981. - Vol. 11, № 2. - P. 127-139
42. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin / A.J. Witkamp [et al.] // Eur. J. Cancer. - 2001. - Vol. 37, № 8. - P. 979-984
43. Glehen, O. Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma / O. Glehen, F.N. Gilly // Surg. Oncol. Clin. N. Am. - 2003. - Vol. 12, № 3. - P. 649-671
44. Selection of patients and staging of peritoneal surface malignancies / E. Cotte [et al.] // World J. Gastrointest. Oncol. - Vol. 2, № 1. - P. 31-35
45. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multiinstitutional study / O. Glehen [et al.] //j. Clin. Oncol. - 2004. - Vol. 22, № 16. - P. 3284-3292
46. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study / B. Sadeghi [et al.] // Cancer. - 2000. - Vol. 88, № 2. - P. 358-363
47. Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multicentre prospective study / E. Cotte [et al.] // Eur. J. Surg. Oncol. - 2013. - Vol. 39, № 7. - P. 707-714
48. Hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from gastric adenocarcinoma / C.R. Rossi [et al.] // Suppl. Tumori. - 2003. - Vol. 2, № 5. - P. S54-57
49. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial / X.J. Yang [et al.] // Ann. Surg. Oncol. - 2011. - Vol. 18, № 6. - P. 1575-1581
50. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study / D. Elias [et al.] //j. Clin. Oncol. - 2010. - Vol. 28, № 1. - P. 63-68
51. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience / T.D. Yan [et al.] //j. Clin. Oncol. - 2009. - Vol. 27, № 36. - P. 6237-6242
52. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy / T.C. Chua [et al.] //j. Clin. Oncol. - 2012. - Vol. 30, № 20. - P. 2449-2456
Review
For citations:
Zabelin M.V., Safonov A.S., Kuznetsov N.V. CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC). HISTORICAL PERSPECTIVE. Bashkortostan Medical Journal. 2021;16(6):78-87. (In Russ.)
Views:
56
Email this article 
